AA
ZURA icon

ALPS Advisors’s Zura Bio ZURA Stock Holding History

ALPS Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$418K Buy
70,192
+16,803
+31% +$102K ﹤0.01% 946
2025
Q4 		$280K Buy
+53,389
New +$211K ﹤0.01% 945

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

ALPS Advisors's ZURA Position: Q1 2026 in Review

ALPS Advisors increased its Zura Bio (ZURA) stake by 31% in Q1 2026, buying an estimated $102K and bringing the position to 70,192 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #946.

ALPS Advisors first reported a position in ZURA in Q4 2025 and has held it in 2 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • ALPS Advisors held 70,192 shares of Zura Bio worth $418K as of Q1 2026.
  • ALPS Advisors bought 16,803 Zura Bio shares in Q1 2026, an estimated $102K.
  • Zura Bio made up ﹤0.01% of ALPS Advisors's portfolio in Q1 2026, its #946 holding.
  • ALPS Advisors first reported a position in Zura Bio in Q4 2025 and has held it in 2 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.